本頁面由Tiger Trade Technology Pte. Ltd.提供服務

ANI Pharmaceuticals, Inc.

70.19
-1.2700-1.78%
盤後70.190.00000.00%19:30 EDT
成交量:37.14萬
成交額:2,617.64萬
市值:16.12億
市盈率:15.46
高:71.92
開:71.53
低:69.58
收:71.46
52周最高:99.39
52周最低:69.58
股本:2,297.04萬
流通股本:2,028.20萬
量比:1.39
換手率:1.83%
股息:- -
股息率:- -
每股收益(TTM):4.54
每股收益(LYR):3.32
淨資產收益率:20.46%
總資產收益率:5.45%
市淨率:2.70
市盈率(LYR):21.14

資料載入中...

2024/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/29

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/23

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/12

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/08

重要事件披露

Form 8-K - Current report
2024/01/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/17

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/18

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities